Issue: February 2019
February 07, 2019
1 min read
Save

COMPASS-CABG

Issue: February 2019
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Researchers compared rivaroxaban (Xarelto, Janssen/Bayer), aspirin or both for the prevention of early coronary bypass graft occlusion in patients with recent CABG.